- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Eagle Pharmaceuticals (NASDAQ:EGRX), Quotes and News Summary
Eagle Pharmaceuticals (NASDAQ: EGRX)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-08 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 3.880 | 4.040 | 0.1600 | ||||
| REV | 123.330M | 115.874M | -7.456M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Eagle Pharmaceuticals Questions & Answers
You can purchase shares of Eagle Pharmaceuticals (NASDAQ: EGRX) through any online brokerage.
Other companies in Eagle Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Cogent Biosciences (NASDAQ:COGT), Immatics (NASDAQ:IMTX), Pharming (NASDAQ:PHAR) and Adicet Bio (NASDAQ:ACET).
The latest price target for Eagle Pharmaceuticals (NASDAQ: EGRX) was reported by Cantor Fitzgerald on Monday, March 2, 2020. The analyst firm set a price target for 46.00 expecting EGRX to rise to within 12 months (a possible 5.19% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Eagle Pharmaceuticals (NASDAQ: EGRX) is $43.73 last updated June 27, 2022, 8:00 PM UTC.
There are no upcoming dividends for Eagle Pharmaceuticals.
Eagle Pharmaceuticals’s Q2 earnings are confirmed for Monday, August 8, 2022.
There is no upcoming split for Eagle Pharmaceuticals.
Eagle Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.